SCM
LLY icon

SCS Capital Management’s Eli Lilly LLY Stock Holding History

SCS Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Sell
11,357
-150
-1% -$153K 0.13% 98
2026
Q1 		$10.6M Buy
11,507
+458
+4% +$464K 0.11% 103
2025
Q4 		$11.9M Sell
11,049
-209
-2% -$200K 0.13% 97
2025
Q3 		$8.59M Sell
11,258
-7,076
-39% -$5.27M 0.09% 111
2025
Q2 		$14.3M Buy
18,334
+11,886
+184% +$9.24M 0.16% 84
2025
Q1 		$5.33M Buy
+6,448
New +$5.37M 0.07% 120

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCS Capital Management's LLY Position: Q2 2026 in Review

SCS Capital Management reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $153K and leaving 11,357 shares worth $13.6M. The position accounts for 0.13% of the portfolio, ranked #98.

SCS Capital Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.3M in Q2 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SCS Capital Management held 11,357 shares of Eli Lilly worth $13.6M as of Q2 2026.
  • SCS Capital Management sold 150 Eli Lilly shares in Q2 2026, an estimated $153K.
  • Eli Lilly made up 0.13% of SCS Capital Management's portfolio in Q2 2026, its #98 holding.
  • SCS Capital Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • SCS Capital Management's Eli Lilly position peaked at $14.3M in Q2 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SCS Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.